Predict your next investment

Debt & Specialty Finance
crglp.com

See what CB Insights has to offer

Investments

34

Portfolio Exits

15

Funds

2

About CRG

CRG, formerly Capital Royalty, is a healthcare-focused investment firm with $1.5 billion of assets under management that provides capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of life science products and technologies and targets investment sizes ranging between $20 million and $200 million. The firm partners with commercial-stage healthcare companies to provide flexible financing solutions so they can achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York City.

CRG Headquarter Location

1000 Main Suite 2500

Houston, Texas, 77002,

United States

713-209-7350

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest CRG News

Texas Roundup: Filament Labs, LiveOak, Capital Royalty, Alafair

May 22, 2014

Submit to Hacker News Here is the latest innovation news from Texas: —Austin, TX-based Filament Labs announced Thursday that it has raised $1 million in seed funding to develop an app that creates digital patient self-care programs with task reminders and educational information and videos. The round was led by Mercury Fund in Houston. —LiveOak Venture Partners closed Tuesday on its inaugural $109 million venture fund aimed at early-stage technology companies. The Austin-based firm began raising money in December and has so far invested in CS Disco , a Houston-based legal IT firm; StepOne , an Austin startup that has developed customer service software; and Veros Systems, which has predictive analytics software. —Capital Royalty in Houston also announced Tuesday that it and New Zealand-based Milford Active Growth Fund have collectively invested $14 million into AFT Pharmaceuticals, which is also based in New Zealand. Capital Royalty will also provide additional capital of up to $30 million in a structured loan facility to the 17-year-old drug company. —Alafair Biosciences last week received a $2 million grant from the Texas Emerging Technology Fund to further the development of the firm’s internal wound-healing devices. Alafair, which is based in Austin, licensed the technology from the University of Texas at Austin. Angela Shah is the editor of Xconomy Texas. She can be reached at ashah@xconomy.com or (214) 793-5763. Follow @angelashah Share or Leave a Comment

CRG Investments

34 Investments

CRG has made 34 investments. Their latest investment was in Treace Medical Concepts as part of their Line of Credit - II on August 8, 2020.

CBI Logo

CRG Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/4/2020

Line of Credit - II

Treace Medical Concepts

$30M

Yes

4

5/21/2019

Line of Credit

Aerin Medical

$50M

Yes

1

3/13/2019

Debt

Harmony Biosciences

$200M

Yes

2

11/27/2018

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

10/22/2018

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/4/2020

5/21/2019

3/13/2019

11/27/2018

10/22/2018

Round

Line of Credit - II

Line of Credit

Debt

Unattributed

Series A - III

Company

Treace Medical Concepts

Aerin Medical

Harmony Biosciences

Subscribe to see more

Subscribe to see more

Amount

$30M

$50M

$200M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

1

2

10

10

CRG Portfolio Exits

15 Portfolio Exits

CRG has 15 portfolio exits. Their latest portfolio exit was Treace Medical Concepts on April 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/23/2021

IPO

$99M

8

2/3/2021

Acquired

$99M

9

12/16/2020

Acquired

1

11/2/2020

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

10/28/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/23/2021

2/3/2021

12/16/2020

11/2/2020

10/28/2020

Exit

IPO

Acquired

Acquired

Reverse Merger

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

9

1

10

10

CRG Fund History

2 Fund Histories

CRG has 2 funds, including CRG Partners IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/11/2019

CRG Partners IV

$229.85M

5

1/4/2017

CRG Partners III

$99M

10

Closing Date

10/11/2019

1/4/2017

Fund

CRG Partners IV

CRG Partners III

Fund Type

Status

Amount

$229.85M

$99M

Sources

5

10

CRG Team

5 Team Members

CRG has 5 team members, including current President, Nathan Hukill.

Name

Work History

Title

Status

Nathan Hukill

Highland Capital Management, and Centennial Ventures

President

Current

Courtney Grobe

Chief Financial Officer, Controller

Current

Luke Duster

Chief Investment Officer, Managing Director

Current

David Carter

Furman Selz, Chemical Financial Corporation, and Morgan Stanley

Founding Partner

Current

Scott Li

Managing Director

Current

Name

Nathan Hukill

Courtney Grobe

Luke Duster

David Carter

Scott Li

Work History

Highland Capital Management, and Centennial Ventures

Furman Selz, Chemical Financial Corporation, and Morgan Stanley

Title

President

Chief Financial Officer, Controller

Chief Investment Officer, Managing Director

Founding Partner

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.